INDIANAPOLIS, Indiana — Diagnostic ID, which offers a system designed to stop mismatching biopsy samples with the wrong patients, is raising $3 million through debt, according to a filing with the Securities & Exchange Commission.
The 1-year-old company offers a service called Know Error that uses a three-step process to cut down on so-called switching errors of prostate biopsies due to mislabeling or misplaced slides, among other things. A swab from a patient’s cheek is sent to a lab, analyzed and assigned a unique barcode identification. Pathology results are then compared to the original swab to confirm a DNA match.
Automation has already drastically cut down on mislabeling errors, though errors can still occur particularly when samples are moved from one place to another — and mistakes usually have nothing to do with the tests themselves. Many errors occur before or after the test is complete.
Transforming Clinical Content with Ambient & Generative AI
Sheila Bond, MD, talked about the latest trends regarding integration of AI in healthcare.
[Photo courtesy of Flickr user sflovestory]
